- Moderna rushed out the news at 10 p.m., with a 4% increase in its share price the next morning...
- What Moderna left out of the release Wednesday, and the media ignored: the mRNA flu jab's disproportionately high rate of serious adverse events compared to a normal flu shot – the same problem with its Omicron-specific COVID vaccine three years ago – and the number of jabs required to prevent a single hospitalization, 5,000...
Important stuff you won't get from the liberal media! We do the surfing so you can be informed AND have a life!
Monday, August 24, 2026
They're lying (half-truth is a lie!) to all of us!-----Science by press release: Moderna cashes in on mRNA cancer vaccine without publishing trial results.
"These corporations have learned how to play the medical-scientific establishment like a Stradivarius," - Greg PiperWhen the Food and Drug Administration approved Moderna's mRNA flu vaccine, the first ever, two weeks ago, the pharmaceutical company that reaped billions from federal taxpayers with its mRNA COVID-19 vaccine didn't wait for the agency to even publicly post the approval.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment